Skip to main content
GLASF
OTC Life Sciences

Glass House Brands Reports Significant 2025 Net Loss, Revenue Decline, and Internal Control Weakness; Secures Waivers for Debt Covenant Breaches

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$7.95
Mkt Cap
$615.539M
52W Low
$3.8
52W High
$10.1
Market data snapshot near publication time

summarizeSummary

Glass House Brands reported a $29.7 million net loss in 2025, a 9% revenue decline, and a material weakness in internal controls. The company secured waivers for debt covenant breaches and faced federal agency actions, despite raising new capital.


check_boxKey Events

  • Significant Net Loss and Revenue Decline

    The company reported a net loss attributable to the company of $29.7 million for the year ended December 31, 2025, a substantial decrease from a net income of $0.5 million in 2024. Net revenues decreased by 9% to $182.0 million, and gross profit margin declined from 48% to 42%.

  • Material Weakness in Internal Control Over Financial Reporting

    Management identified a material weakness in internal control over financial reporting related to information technology general controls (ITGCs) due to insufficient evidence regarding third-party service providers' internal controls.

  • Debt Covenant Violations and Waivers

    As of December 31, 2025, Glass House Brands was not in compliance with financial covenants for its $50 million Senior Secured Credit Facility (Fixed-Charge Coverage Ratio) and its $3 million 2025 Lompoc Term Loan (Debt Service Coverage Ratio). Waivers were obtained in March 2026, suspending testing until Q4 2026, preventing immediate debt acceleration.

  • Federal Agency Actions and Operational Disruptions

    On July 10, 2025, U.S. Immigration and Customs Enforcement (ICE) executed search warrants at two of the company's cultivation facilities in connection with immigration-related matters, leading to operational disruptions and a fatal injury involving a third-party contractor. The investigation is ongoing.


auto_awesomeAnalysis

Glass House Brands Inc. reported a challenging fiscal year 2025 with a substantial net loss of $29.7 million, a significant decline from a net income of $0.5 million in 2024. Revenues decreased by 9% to $182.0 million, and gross profit margin fell from 48% to 42%. The company also disclosed a material weakness in its internal control over financial reporting related to IT general controls. Critically, Glass House Brands was not in compliance with financial covenants for both its Senior Secured Credit Facility and the 2025 Lompoc Term Loan as of December 31, 2025, necessitating waivers obtained in March 2026 to prevent debt acceleration. These waivers provide a temporary reprieve but highlight underlying financial fragility. Additionally, the company faced federal agency actions in July 2025, including ICE search warrants at two facilities, which led to operational disruptions and a fatal injury involving a third-party contractor. While the company successfully raised $77.5 million through preferred equity and $6.2 million from its ATM program in 2025 (with an additional $18.7 million post-period), and resolved certain litigation, the overall financial performance and compliance issues present significant concerns for investors.

At the time of this filing, GLASF was trading at $7.95 on OTC in the Life Sciences sector, with a market capitalization of approximately $615.5M. The 52-week trading range was $3.80 to $10.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed GLASF - Latest Insights

GLASF
Apr 28, 2026, 6:33 PM EDT
Filing Type: 6-K
Importance Score:
8
GLASF
Mar 24, 2026, 5:08 PM EDT
Filing Type: 40-F
Importance Score:
8
GLASF
Mar 24, 2026, 4:11 PM EDT
Filing Type: 6-K
Importance Score:
8